Richard Klausner, Sr VP, Chief Medical Officer at Illumina, holds 3.90M shares in Lyell Immunopharma (Ticker: LYEL), holds 0.00 shares in Juno Therapeutics (Ticker: JUNO), holds 22.85K shares in Illumina (Ticker: ILMN). Most recently, Richard Klausner Sold ― shares of Lyell Immunopharma on Aug 17, 2023 for an estimated value of 132.29K.